| Net Cash Provided by (Used in) Operating Activities |
$35,984,000 |
USD |
606% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$42,497,000 |
USD |
-334% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
32,539,522 |
shares |
5.9% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$6,513,000 |
USD |
-39% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$40,822,000 |
USD |
-24% |
Q4 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$8,602,000 |
USD |
-40% |
Q1 2025 |
Q1 2025 |
| Additional Paid in Capital |
$708,655,000 |
USD |
6.3% |
Q4 2025 |
FY 2025 |
| Interest Expense |
$54,063,000 |
USD |
60% |
Q1 2024 |
Q1 2024 |